Global Biosimilar Monoclonal Antibodies Market Threats, Analysis, Key Players, Growth, and Forecast 2026

Growth of biosimilar monoclonal antibodies market expected to be significantly driven by revenue contribution from Asia Pacific market over next 10 years.

Monoclonal antibodies (mAb) are antibodies produced by using identical immune cells that are clones of one unique parent cell. Since monoclonal antibodies are produced from clones of only one parent cell, all monoclonal antibodies produced by the parent cell are the same due to which, they are called biosimilar monoclonal antibodies. A monovalent antibody can be antibody with affinity that can bind the same epitope, antigen, or strain of microorganism that is recognized by the antibody.

A monoclonal antibody is a laboratory-made protein that can bind to substances in the body such as cancer cells. It is made in such a way that it binds to only one substance to treat a specific type of cancer. Different monoclonal antibodies are required to be made to target different types of cancers as each monoclonal antibody recognizes their respective protein and work in different ways, depending on the protein they are targeting.

Rising prevalence of chronic diseases such as cancers, rising incidence of patient expiration for several biologics, improvised products, and expanding healthcare infrastructure are key factors driving growth of the global biosimilar monoclonal antibodies market. Other factors include rising adoption rate and demand for cost-effective diagnosis and treatments, collaboration and mergers between global and local players are expected to result is significant for this market. However, stringent government regulatory policies for development of biosimilar monoclonal antibodies and unfavorable manufacturing procedures and associated cost structure are restraining growth of the global biosimilar monoclonal antibodies market.

Europe market accounts for major revenue share contribution to the global biosimilar monoclonal antibodies market owing to early adoption of biosimilars, being the first region to draft guidelines, favorable government regulations and policies.

Asia Pacific market is expected to register a significant CAGR in revenue terms in the next 10 years and create high potential opportunities for players in the market in the region. This is attributed to increasing awareness, cost effective treatments, rising prevalence of chronic diseases, continuous research and development of new biosimilar monoclonal antibodies etc. Moreover, investment by government and efforts by healthcare associations to widen scope for the healthcare industry are factors anticipated to create further opportunities for growth of the biosimilar monoclonal antibodies market in this region.

Among the various compound segments, revenue from rituximab and infliximab segments is significantly higher than that from others. Revenue from rituximab segment is higher than that of the infliximab segment, and is expected to expand at the highest CAGR and continue to dominate the market in terms of revenue generation throughout the forecast period.

Market segmentation and key players:

Global biosimilar monoclonal antibodies market segmentation by compound:

 	
Infliximab
 	
Rituximab
 	
Abciximab
 	
Trastuzumab
 	
Adalimumab
 	
Bevacizumab

Global biosimilar monoclonal antibodies market segmentation by products:

 	
Remsima/Inflectra
 	
Infimab
 	
Reditux
 	
BI695500
 	
CT-P10
 	
BI695501
 	
FKB327
 	
FKB238
 	
Mabtas
 	
AcellBia
 	
Maball
 	
Clotinab
 	
Abcixirel
 	
BCD-022
 	
BCD-021
 	
Herzuma
 	
CANMAB/Hertraz

Companies profiled:

 	
Allergan plc
 	
BIOCADBioXpress
 	
Therapeutics SA
 	
Biocon
 	
Boehringer Ingelheim GmbH
 	
Celltrion Inc.
 	
Coherus BioSciences Inc.
 	
Reddy’s Laboratories Ltd.
 	
Genor BioPharma Co. Ltd.
 	
Intas Pharmaceuticals Limited
 	
Novartis AG
 	
Pfizer Inc.
 	
Reliance Life Sciences

Report Structure:

In the first section of the report we offer a table of content, followed by a list of figures. The next section offers a definition and brief explanation of the various products and segmentation of the target market, along with research methodology and a list of acronyms and sources used to gather and analyze data and information.

The third section of the report entails a brief list of drivers, restraints, opportunities, and threats (DROTs) in the target market. The report also offers insights on various trends in regions, countries, and markets as per segmentation, as well as insights and crucial information obtained from various sources including primary and secondary, annual reports, the Internet and others.

The final section comprises detailed profiles of key players in the target market and a SWOT analysis of each company, apart from strategies, acquisitions and mergers.

Objective of Report:

Sections of the report are created and designed specifically to offer readers a clear, clean, and insights into historical, estimated, and revenue (US$ Mn/Bn) estimation and projection, Compounded Annual Growth Rate (CAGR %), and volume in measure as applicable to the target product/market. We offer illustrations, charts, tables, and figures to support our findings and analysis, in addition to key finding for markets in regions and countries. This report is valuable asset for the existing players, new entrants and the future investors.

Who we are and what we do:

Market.biz is a pioneering company in the fields of market research and analytical reporting. Our services enable clients to enhance business efficiency and focus on other core aspects of operations, while we take care of market research and reporting needs. Market.biz conducts and executes detailed and in-depth research and analysis across all relevant domains and offers accurate and insightful estimations and forecasts to enable clients to take well-informed and crucial decisions in their respective industries, sectors, or companies.

Market.biz has access to the world’s most comprehensive and up-to-date databases in any business sector, as we understand the specific and varying needs of our clients. We offer updated reports to keep up with the changing scenarios in global markets and strive to ensure that only the utmost quality is established and maintained in every single report we produce. Our reports are conveniently designed and structured and are visually-pleasing. We provide a detailed analysis outlook of competitive markets and identify and study new and emerging trends and other crucial aspects and factors impacting or driving market growth. We also offer insights regarding new and emerging opportunities in the market and present the information in a comprehensive report focused on your respective market or sector.